(E)-Cefotaxime
CAS: 63527-53-7
Ref. 3D-NCA52753
| 1mg | 943.00 € | ||
| 5mg | 2,507.00 € | ||
| 10mg | 4,011.00 € | ||
| 25mg | 7,520.00 € | ||
| 50mg | 12,031.00 € |
Product Information
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2E)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)-
- R 02-5328A
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2E)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)-
- (6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2E)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6α,7β(E)]]-
(E)-Cefotaxime is a potent inhibitor of kinases that has been shown to induce apoptosis in cancer cells. It is an analog of the antibiotic cefotaxime and has been found in human urine. (E)-Cefotaxime has demonstrated anticancer activity in Chinese hamster ovary cells, inhibiting tumor growth and inducing apoptosis. This drug also shows promise as a potential therapy for cancer due to its ability to inhibit protein kinase activity. In addition, (E)-Cefotaxime may have potential applications as an inhibitor of other kinases involved in various diseases.
Chemical properties
Technical inquiry about: 3D-NCA52753 (E)-Cefotaxime
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
